May 19, 2016
Oncology and the Affordable Care Act
Video Categories: Affordable Care ActRelated Videos
July 13, 2021
Distinctions and Parallels Among TRK Inhibitors
Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, explore the mutual and contrasting features of TRK inhibitors.
January 13, 2015
Benefits of Breast Cancer Index
Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.